Webhaber
Arthritis drug Humira's two-decade reign ends as Amgen launches competing biosimilar

Arthritis drug Humira's two-decade reign ends as Amgen launches competing biosimilar

The price of Amgen's rheumatoid arthritis drug called Amjevita is up to 55% less than the widely-prescribed Humira.     

Usa Today, Benzer haberler